These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 22438980)
21. Dopamine D2 receptor dysfunction is rescued by adenosine A2A receptor antagonism in a model of DYT1 dystonia. Napolitano F; Pasqualetti M; Usiello A; Santini E; Pacini G; Sciamanna G; Errico F; Tassone A; Di Dato V; Martella G; Cuomo D; Fisone G; Bernardi G; Mandolesi G; Mercuri NB; Standaert DG; Pisani A Neurobiol Dis; 2010 Jun; 38(3):434-45. PubMed ID: 20227500 [TBL] [Abstract][Full Text] [Related]
22. [Clinical and genetic analysis of childhood-onset myoclonus dystonia syndrome caused by SGCE variants]. Tian XJ; Ding CH; Zhang YH; Dai LF; Chen CH; Li JW; Wang X; Han TL; Wang XH; Deng J Zhonghua Er Ke Za Zhi; 2020 Feb; 58(2):123-128. PubMed ID: 32102149 [No Abstract] [Full Text] [Related]
23. Genetic Aspects of Myoclonus-Dystonia Syndrome (MDS). Rachad L; El Kadmiri N; Slassi I; El Otmani H; Nadifi S Mol Neurobiol; 2017 Mar; 54(2):939-942. PubMed ID: 26790671 [TBL] [Abstract][Full Text] [Related]
24. The electroretinogram as a biomarker of central dopamine and serotonin: potential relevance to psychiatric disorders. Lavoie J; Illiano P; Sotnikova TD; Gainetdinov RR; Beaulieu JM; Hébert M Biol Psychiatry; 2014 Mar; 75(6):479-86. PubMed ID: 23305992 [TBL] [Abstract][Full Text] [Related]
26. A novel conserved mutation in SGCE gene in 3 unrelated patients with classical phenotype myoclonus-dystonia syndrome. Szubiga M; Rudzińska M; Bik-Multanowski M; Pietrzyk JJ; Szczudlik A Neurol Res; 2013 Jul; 35(6):659-62. PubMed ID: 23561547 [TBL] [Abstract][Full Text] [Related]
27. Striatal cholinergic transmission in an inducible transgenic mouse model of paroxysmal non-kinesiogenic dyskinesia. Scarduzio M; Eskow Jaunarajs KL; Standaert DG Neurobiol Dis; 2024 Oct; 201():106685. PubMed ID: 39343248 [TBL] [Abstract][Full Text] [Related]
28. Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA. Granado N; Ares-Santos S; Oliva I; O'Shea E; Martin ED; Colado MI; Moratalla R Neurobiol Dis; 2011 Jun; 42(3):391-403. PubMed ID: 21303698 [TBL] [Abstract][Full Text] [Related]
30. Myoclonus-dystonia (DYT11) with novel SGCE mutation misdiagnosed as a primary psychiatric disorder. Bonello M; Larner AJ; Alusi SH J Neurol Sci; 2014 Nov; 346(1-2):356-7. PubMed ID: 25204586 [No Abstract] [Full Text] [Related]
31. Cortical neuronal hyperexcitability and synaptic changes in SGCE mutation-positive myoclonus dystonia. Sperandeo A; Tamburini C; Noakes Z; de la Fuente DC; Keefe F; Petter O; Plumbly W; Clifton NE; Li M; Peall KJ Brain; 2023 Apr; 146(4):1523-1541. PubMed ID: 36204995 [TBL] [Abstract][Full Text] [Related]
32. Decreased dopamine receptor 1 activity and impaired motor-skill transfer in Dyt1 ΔGAG heterozygous knock-in mice. Yokoi F; Dang MT; Liu J; Gandre JR; Kwon K; Yuen R; Li Y Behav Brain Res; 2015 Feb; 279():202-10. PubMed ID: 25451552 [TBL] [Abstract][Full Text] [Related]
33. Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome. Zimprich A; Grabowski M; Asmus F; Naumann M; Berg D; Bertram M; Scheidtmann K; Kern P; Winkelmann J; Müller-Myhsok B; Riedel L; Bauer M; Müller T; Castro M; Meitinger T; Strom TM; Gasser T Nat Genet; 2001 Sep; 29(1):66-9. PubMed ID: 11528394 [TBL] [Abstract][Full Text] [Related]
34. Myoclonus-dystonia due to maternal uniparental disomy. Guettard E; Portnoi MF; Lohmann-Hedrich K; Keren B; Rossignol S; Winkler S; El Kamel I; Leu S; Apartis E; Vidailhet M; Klein C; Roze E Arch Neurol; 2008 Oct; 65(10):1380-5. PubMed ID: 18852357 [TBL] [Abstract][Full Text] [Related]
35. Function of dopamine transporter is compromised in DYT1 transgenic animal model in vivo. Hewett J; Johanson P; Sharma N; Standaert D; Balcioglu A J Neurochem; 2010 Apr; 113(1):228-35. PubMed ID: 20132487 [TBL] [Abstract][Full Text] [Related]
36. The neurophysiological features of myoclonus-dystonia and differentiation from other dystonias. Popa T; Milani P; Richard A; Hubsch C; Brochard V; Tranchant C; Sadnicka A; Rothwell J; Vidailhet M; Meunier S; Roze E JAMA Neurol; 2014 May; 71(5):612-9. PubMed ID: 24638021 [TBL] [Abstract][Full Text] [Related]
37. Characterization of the direct pathway in Dyt1 ΔGAG heterozygous knock-in mice and dopamine receptor 1-expressing-cell-specific Dyt1 conditional knockout mice. Yokoi F; Chen HX; Oleas J; Dang MT; Xing H; Dexter KM; Li Y Behav Brain Res; 2021 Aug; 411():113381. PubMed ID: 34038798 [TBL] [Abstract][Full Text] [Related]
38. A child with myoclonus-dystonia (DYT11) misdiagnosed as atypical opsoclonus myoclonus syndrome. Drivenes B; Born AP; Ek J; Dunoe M; Uldall PV Eur J Paediatr Neurol; 2015 Nov; 19(6):719-21. PubMed ID: 26278497 [TBL] [Abstract][Full Text] [Related]
39. Role of aberrant striatal dopamine D1 receptor/cAMP/protein kinase A/DARPP32 signaling in the paradoxical calming effect of amphetamine. Napolitano F; Bonito-Oliva A; Federici M; Carta M; Errico F; Magara S; Martella G; Nisticò R; Centonze D; Pisani A; Gu HH; Mercuri NB; Usiello A J Neurosci; 2010 Aug; 30(33):11043-56. PubMed ID: 20720111 [TBL] [Abstract][Full Text] [Related]
40. A neurophysiological study of myoclonus in patients with DYT11 myoclonus-dystonia syndrome. Marelli C; Canafoglia L; Zibordi F; Ciano C; Visani E; Zorzi G; Garavaglia B; Barzaghi C; Albanese A; Soliveri P; Leone M; Panzica F; Scaioli V; Pincherle A; Nardocci N; Franceschetti S Mov Disord; 2008 Oct; 23(14):2041-8. PubMed ID: 18759336 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]